Anti-tumoral
![qualité 3-(4-phénoxy-phényl)-1-piperidine-3-yl-1H-pyrazolo[3,4-d]pyriMidin-4-ylaMine (1022150-12-4) usine](http://style.farmasino.net/images/load_icon.gif){kind=icon}
3-(4-phénoxy-phényl)-1-piperidine-3-yl-1H-pyrazolo[3,4-d]pyriMidin-4-ylaMine (1022150-12-4)
3-(4-Phenoxy-phenyl)-1-piperidin-3-yl-1H-pyrazolo[3,4-d]pyriMidin-4-ylaMine (1022150-12-4) is a key intermediate of Ibrutinib. Product Name: 3-(4-Phenoxy-phenyl)-1-piperidin-3-yl-1H-pyrazolo[3,4-d]pyriMidin-4-ylaMine CAS No.: 1022150-12-4 Assay: 98% End Use: Ibrutinib Molecular Formula: C22H22N6O Molecular Weight: 386.45 Shelf Life: 2 Years Package: 25kg/drum
(S) -tert-butyle 3-(4-aMinophényle)piperidine-1-carboxylate (1171197-20-8)
(S)-tert-butyl 3-(4-aMinophenyl)piperidine-1-carboxylate is a key intermediate of Niraparib. Product Name: (S)-tert-butyl 3-(4-aMinophenyl)piperidine-1-carboxylate CAS No.: 1171197-20-8 Assay: 98% End Use: Niraparib Tosylate Monohydrate Molecular Formula: C16H24N2O2 Molecular Weight: 276.37 Shelf Life: 2 Years Package: 25kg/drum
Le méthyl-3-formyl-2-nitrobenzoate (138229-59-1)
Methyl 3-formyl-2-nitrobenzoate is a key intermediate of Niraparib. Product Name: Methyl 3-formyl-2-nitrobenzoate CAS No.: 138229-59-1 Assay: 98% End Use: Niraparib Tosylate Monohydrate Molecular Formula: C9H7NO5 Molecular Weight: 209.16 Shelf Life: 2 Years Package: 25kg/drum
Niraparib tosylate monohydraté (1613220-15-7)
Niraparib is used to treat recurrent epithelial ovarian cancer, fallopian tube cancer, and primary peritoneal cancer that respond to platinum-based chemotherapy. Product Name: Niraparib tosylate monohydrate CAS No.: 1613220-15-7 Assay: 98% Specification: CP, EP, In-house, as required Molecular Formula: C26H28N4O4S Molecular Weight: 492.59 Shelf Life: 2 Years Package: 25kg/drum
Niraparib (forme libre libre alcaline) (1038915-60-4)
Niraparib is free alkali form of Niraparib tosylate monohydrate. Product Name: Niraparib (free free alkali form) CAS No.: 1038915-60-4 Assay: 98% End Use: Niraparib Tosylate Monohydrate Molecular Formula: C19H20N4O Molecular Weight: 320.39 Shelf Life: 2 Years Package: 25kg/drum
Enasidénib mésylate (1650550-25-6)
Enasidenib is a first-in-class oral selective inhibitor of mutant IDH2 enzymes (isocitrate dehydrogenase 2), for the treatment of adults with relapsed or refractory IDH2-mutated acute myeloid leukemia. Product Name: Enasidenib mesylate CAS No.: 1650550-25-6 Assay: 98% Specification: CP, EP, In-house, as required Molecular Formula: C20H21F6N7O4S Molecular Weight: 569.48 Shelf Life: 2 Years Package: 25kg/drum
Les produits visés à l'annexe II du présent règlement sont des produits qui sont dérivés de la même substance.3,5-triazine-2-amine (1446507-68-1)
4-chloro-6-(6-(trifluoromethyl)pyridin-2-yl)-N-(2-(trifluoromethyl)pyridin-4-yl)-1,3,5-triazin-2-amine is an intermediate of Enasidenib mesylate. Product Name: 4-chloro-6-(6-(trifluoromethyl)pyridin-2-yl)-N-(2-(trifluoromethyl)pyridin-4-yl)-1,3,5-triazin-2-amine CAS No.: 1446507-68-1 Assay: 98% End Use: Enasidenib mesylate Molecular Formula: C15H7ClF6N6 Molecular Weight: 420.7 Shelf Life: 2 Years Package: 25kg/drum
1-amino-2-méthylpropan-2-ol (2854-16-2)
1-Amino-2-methylpropan-2-ol is an intermediate of Enasidenib mesylate. Product Name: 1-Amino-2-methylpropan-2-ol CAS No.: 2854-16-2 Assay: 98% End Use: Enasidenib mesylate Molecular Formula: C4H11NO Molecular Weight: 89.14 Shelf Life: 2 Years Package: 25kg/drum
